Turn this role into an interview — a resume and cover letter built around what this employer wants.
GSK is seeking a Lab Analyst to ensure quality compliance across raw materials, in-process and finished products, including stability testing. You will coordinate GMP adherence, contribute to validation programs and support documentation updates.
The role requires a bachelor’s in chemistry or related field and 1–2 years in a pharma QC lab, with hands-on instrument experience and a proactive approach to quality and safety.
The Lab Analyst will ensure Quality Compliance of Products / Materials at various stages of testing (including raw material, intermediate and finished product & stability testing) to fulfill regulatory and GMP/GLP requirements, coordinate for the fulfillment of GMP compliance and various quality requirements as per GQMPs and GQPs and manage the product validation program in line with GMP requirements.
Data Integrity, Detail-Oriented, Digital Fluency, GxP Regulations, Lean Management, Problem Solving, Quality Assurance (QA), Quality Control (QC), Risk Awareness, Testing Operations
Uniting science, technology and talent to get ahead of disease together.
GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale.
People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.